Medtronic has received FDA clearance for a mobile app that allows patients to remotely forward data from their pacemakers with their physicians. The app is paired with a device, the MyCareLink Smart ...

Medtronic has announced FDA approval and U.S. commercial availability of its free MyCareLink Smart Monitor. The smart mobile application in combination with the prescribed handheld device reader will ...

A pacemaker from Medtronic, newly approved by the Food and Drug Administration, allows patients to securely transmit data from the pacemaker to their physicians via a smartphone or tablet using ...

FDA Approves New ICDs and CRT-Ds with Advanced Remote Capabilities DUBLIN, May 08, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced results from late-breaking clinical trials ...

The U.S. Food and Drug Administration has given Medtronic (NYSE:MDT) the go-ahead on a clinical trial to test its next generation of MRI pacemaker technology, the Minnesota company announced Monday.

COLLEGE PARK, Md., March 19 (Reuters) - Medtronic Inc's experimental MRI-safe pacemaker should be approved despite limited clinical data as long as further study is done, U.S. health advisers ...

MINNEAPOLIS — Medtronic Inc., the world's largest medical device company, said Tuesday it received U.S. approval for the first pacemaker designed to be safely used with MRI scanners. Patients with the ...

DUBLIN, Jan. 5, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it has received CE (Conformité Européenne) Mark for its Micra™ AV2 and Micra™ ...

Medtronic announced today that it initiated a pivotal study evaluating the use of cardiac pacing rates in a new patient population.